Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Few-shot learning enhances biomarker identification

Jan. 29, 2021

Chinese investigators describe new KRAS mutant inhibitors

Jan. 28, 2021

Nuvation Bio identifies new BET inhibitors

Jan. 28, 2021

Suzhou Kintor Pharmaceuticals patents c-MYC inhibitors

Jan. 28, 2021

IMPACT Therapeutics presents ATM kinase inhibitors

Jan. 28, 2021

LINC01271 is a therapeutic target in breast cancer

Jan. 28, 2021

Maytansinoid analogue conjugated to gold nanoparticles inhibits tumor growth in HCC mouse model

Jan. 28, 2021

DPP-4 inhibitor sitagliptin prevents incidence of GvHD after allogeneic HSCT in AML

Jan. 27, 2021

FDA allows Cardif Oncology to proceed with phase II trial of onvansertib in PDAC

Jan. 27, 2021

New CDK inhibitors patented by Nuvation Bio

Jan. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...